AZD4076 NCT02826525


Laboratory : ASTRAZENENKA

Study Name : 

Phase 2

Study Number : NCT02826525

Number of patients recruited : 51

Probability to be under placebo : 50%

Contacts : 

Contact: AstraZeneca Clinical Study Information Center

1-877-240-9479

information.center@astrazeneca.com






Share on StockTwits

WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016